Xilio Therapeutics Competitors and Similar CompaniesClear all
Xilio Therapeutics's competitors and similar companies include Kiromic Biopharma, Kite Pharma and RAPT Therapeutics.
 Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. |  Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2009 | Founding Date 2015 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Waltham, US HQ | Locations Houston, US HQ | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations South San Francisco, US HQ |
Employees | Employees 69 | Employees 4426% increase | Employees 3,9671% decrease | Employees 64 |
Valuation ($) | Valuation ($) 43.5 m | Valuation ($) 1.8 m | Valuation ($) N/A | Valuation ($) 69.8 m |
Financial | ||||
Net income | Net income ($35m) (FY, 2025) | Net income ($26.9m) (FY, 2024) | Net income N/A | Net income ($129.9m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 233m | Total funding raised $ 135k | Total funding raised $ 85.3m | Total funding raised $ 176m |
For sources of this data, please see the company profile
View Company Profiles
Kiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
Kite Pharma
HQ
Santa Monica, US
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
View companyRAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company